Who is sponsoring NCT03197597?

NCT03197597 is sponsored by University of Turku.

What drugs are being tested in NCT03197597?

Interventions in NCT03197597: Strain isolation from the nasopharynx.

What condition does NCT03197597 study?

NCT03197597 studies Bordetella Pertussis, Whooping Cough.

Is NCT03197597 still recruiting?

NCT03197597 is currently completed. Last updated 23 June 2017.

Last reviewed 2017-06-23 · How we verify

NCT03197597

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

EUpertstrain 4 Study of Bordetella Pertussis Isolates

Completed Last updated 23 June 2017

What this trial tests

trial testing Strain isolation from the nasopharynx in Bordetella Pertussis, Whooping Cough in 265 participants. Completed in 31 December 2016.

Timeline

12 October 2015

Primary endpoint
31 December 2016

31 December 2016

Quick facts

Lead sponsor	University of Turku
Status	Completed
Study type	OBSERVATIONAL
Enrollment	265
Start date	12 October 2015
Primary completion	31 December 2016
Estimated completion	31 December 2016
Sites	1 location across Finland

Drugs / interventions tested

Strain isolation from the nasopharynx

Conditions studied

Bordetella Pertussis, Whooping Cough — all drugs for Bordetella Pertussis, Whooping Cough →

Sponsor

University of Turku

Who can join

Eligibility, any sex, with Bordetella Pertussis, Whooping Cough. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study focus on the genetic changes of B. pertussis clinical isolates. For this panels of B. pertussis isolates has been collected during four periods in different European countries.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Pertactin-deficient <i>Bordetella pertussis</i> isolates: evidence of increased circulation in Europe, 1998 to 2015.
Barkoff AM, Mertsola J, Pierard D, Dalby T, et al · · 2019 · cited 73× · PMID 30782265 · DOI 10.2807/1560-7917.es.2019.24.7.1700832

Verify or expand the search:

Other recruiting trials for Bordetella Pertussis, Whooping Cough

Currently open trials in the same condition.

NCT06640387 — CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools · recruiting
NCT05897879 — Impact of Bacterial Expression and Immune Response in the Severity of Pertussis · NA · recruiting

Other University of Turku trials

Trials by the same sponsor.

NCT07084389 — A Financial Social Work Intervention for Families With Complex Financial Difficulties (FinSoc) · NA · recruiting
NCT06886581 — Online Training Course to Improve Evidence-based Leadership · NA · recruiting
NCT06856408 — Power of Growth - Digitally Assisted Intervention for the Early Childhood Educators' Self-efficacy Teamwork and Children · NA · recruiting
NCT06627868 — Nicotinamide Adenine Dinucleotide (NAD+) Metabolism in Human Brown Adipose Tissue · NA · recruiting
NCT06284772 — FINRISK 2002 Re-examination · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03197597 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Turku
Last refreshed: 23 June 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03197597.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing